-
-
We strive to improve access to medicines through the development and provision of innovative medicines.
-
Recognizing that patients and consumers are the key players in healthcare, all employees are recommended to spend 1% of their working hours with patients
-
August 6, 2020
EISAI SUPPORTS RELIEF EFFORTS FOR THE HEAVY RAIN EVENT OF JULY 2020 IN JAPAN
-
July 30, 2020
-
July 28, 2020
-
July 27, 2020
-
July 22, 2020
-
August 4, 2020
-
August 3, 2020
IR “First Quarter Financial Report for the Fiscal Year Ending March 31, 2021”
-
July 3, 2020
Video about Improving Access to Medicines "Leave No One Behind -Disease of Neglected People-"
-
June 22, 2020
IR "Notice of Shareholder Voting Results for the 108th Ordinary General Meeting of Shareholders"
-
June 22, 2020
-
August 4, 2020
Notice of Emergence of Employees Infected with the Novel Coronavirus at Eisai’s Vizag Plant in India
-
February 14, 2020
EISAI TO VOLUNTARILY WITHDRAW ANTIOBESITY AGENT BELVIQ® / BELVIQ XR® IN THE U.S.
-
October 18, 2019
EISAI JOINS WORLD ECONOMIC FORUM AS STRATEGIC PARTNER ASSOCIATE
-
July 8, 2019
-
July 4, 2019
Eisai's hhc Philosophy
Sustainability
28 countries 2.0 billion tablets
Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of July 2020)
Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries
